| S7380 | 
                                    
                                        
                                        
                                            Leupeptin Hemisulfate
                                        
                                     | 
                                    Leupeptin Hemisulfate is a reversible inhibitor of serine and cysteine proteases. It inhibits cathepsin B (Ki = 6 nM), calpain (Ki = 10 nM), trypsin (Ki = 35 nM), plasmin (Ki = 3.4 μM), and kallikrein (Ki = 19 μM), and has no effect against chymotrypsin, elastase, renin, or pepsin. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Adv Mater, 2025, e18445.
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Nat Commun, 2025, 16(1):4069
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        J Adv Res, 2025, S2090-1232(25)00056-6
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S3025 | 
                                    
                                        
                                        
                                            PMSF 
                                        
                                     | 
                                    PMSF (Phenylmethylsulfonyl Fluoride, Benzylsulfonyl fluoride) is an irreversible serine/cysteine protease inhibitor. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Cell Death Discov, 2024, 10(1):171
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Cell Biosci, 2023, 13(1):9
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Cell Biosci, 2023, 13(1):9
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S1811 | 
                                    
                                        
                                        
                                            Amiloride HCl
                                        
                                     | 
                                    Amiloride HCl is a selective T-type calcium channel blocker, an epithelial sodium channel blocker and a selective inhibitor of urokinase plasminogen activator (uPA)(Ki=7 μM). | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        J Extracell Vesicles, 2024, 13(4):e12426
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        J Extracell Vesicles, 2024, 13(4):e12426
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Virus Res, 2024, 339:199258
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S1386 | 
                                    
                                        
                                        
                                            Nafamostat mesilate (FUT-175)
                                        
                                     | 
                                    Nafamostat mesilate is a synthetic serine protease inhibitor, used as an anticoagulant during hemodialysis. Nafamostat mesylate blocks activation of SARS-CoV-2 and is investigated as a new treatment option for COVID-19. Nafamostat Mesilate attenuates inflammation and apoptosis. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        J Immunother Cancer, 2024, 12(11)e009805
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Cell Death Dis, 2024, 15(2):109
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        CNS Neurosci Ther, 2024, 30(6):e14822
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                            
                                                 
                                            
                                        
                                     | 
                                
                            
                                
                                    | S8136 | 
                                    
                                        
                                        
                                            Sivelestat
                                        
                                     | 
                                    Sivelestat is a potent and selective inhibitor of neutrophil elastase with IC50 of 44nM. It almost shows no activity at a range of other proteases. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Redox Biol, 2025, 87:103881
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        J Immunother Cancer, 2025, 13(2)e010813
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Int Immunopharmacol, 2025, 151:114340
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S7378 | 
                                    
                                        
                                        
                                            AEBSF HCl
                                        
                                     | 
                                    AEBSF HCl is a broad spectrum, irreversible serine protease inhibitor.
 | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Acta Pharm Sin B, 2024, 14(6):2554-2566
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Int J Med Sci, 2024, 21(7):1204-1212
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Int J Biol Sci, 2023, 19(13):4327-4339
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S4666 | 
                                    
                                        
                                        
                                            Sivelestat sodium tetrahydrate
                                        
                                     | 
                                    Sivelestat sodium tetrahydrate (ONO5046-Na, EI546, LY544349) is a competitive inhibitor of human neutrophil elastase, also inhibits leukocyte elastase obtained from rabbit, rat, hamster and mouse. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        J Thorac Dis, 2024, 16(10):6616-6633
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        J Immunol, 2021, 206(4):797-806
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Aging (Albany NY), 2020, 12(17):16820-16836
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S2101 | 
                                    
                                        
                                        
                                            Gabexate Mesylate
                                        
                                     | 
                                    Gabexate Mesylate(FOY) is a serine protease inhibitor with IC50 of 0.19 μM which is used therapeutically in the treatment of pancreatitis and disseminated intravascular coagulation. | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        iScience, 2024, 27(10):110862
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Curr Res Chem Biol, 2022, 2:100023
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Front Oncol, 2019, 0.87569444444
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                            
                                                 
                                            
                                        
                                     | 
                                
                            
                                
                                    | S7218 | 
                                    
                                        
                                        
                                            Alvelestat (AZD9668)
                                        
                                     | 
                                    Alvelestat (AZD9668, Avelestat) is an oral, highly selective inhibitor of neutrophil elastase (NE) with IC50 and Ki of 12 nM and 9.4 nM, at least 600-fold more selective over other serine proteases.
 Phase 2.
 | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Cell Death Discov, 2025, 11(1):29
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Int Immunopharmacol, 2025, 159:114860
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Proc Natl Acad Sci U S A, 2021, 118(34)e2102435118
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S8457 | 
                                    
                                        
                                        
                                            UK-371804 HCl
                                        
                                     | 
                                    UK-371804 is a potent and selective urokinase-type plasmogen activator (uPA) inhibitor with excellent enzyme potency (Ki=10 nM) and selectivity profile (4000-fold versus tPA and 2700-fold versus plasmin). | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        PNAS Nexus, 2022, 1(3):pgac104
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Front Genet, 2021, 12:651882
                                                    
 
                                                 
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S7377 | 
                                    
                                        
                                        
                                            Aprotinin
                                        
                                     | 
                                    Aprotinin is a small protein serine protease inhibitor (Kd=0.06 pM for bovine β-trypsin), used to reduce perioperative blood loss and transfusion.
 | 
                                    
                                        
                                            
                                                
                                                    - 
                                                        Front Cell Neurosci, 2025, 19:1623747
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        J Immunother Cancer, 2024, 12(11)e009805
                                                    
 
                                                 
                                            
                                        
                                            
                                                
                                                    - 
                                                        Elife, 2021, 10e65962
                                                    
 
                                                 
                                            
                                        
                                            
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | E7249New | 
                                    
                                        
                                        
                                            Ulinastatin
                                        
                                     | 
                                    Ulinastatin (Uristatin) is the main inhibitor of a hydrolase protein and serine protease suppresses trypsin, chymotrypsin, and other pancreatic proteases. It can inhibit the production and release of inflammatory factors through mediating inflammatory pathways, while modulating apoptosis, enzyme activity, coagulation, and immune responses. It is effective in preventing and managing conditions like pancreatitis, cerebral edema, acute respiratory distress, circulatory failure, sepsis, and systemic inflammatory response syndrome. | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S0042 | 
                                    
                                        
                                        
                                            Fulacimstat
                                        
                                     | 
                                    Fulacimstat (BAY1142524) is an orally available inhibitor of chymase with IC50 of 4 nM and 3 nM for human and hamster chymase enzyme, respectively. | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S3511 | 
                                    
                                        
                                        
                                            FOY251
                                        
                                     | 
                                    FOY251, an active metabolite of camostat mesilate, is an inhibitor of synthetic serine protease. FOY251 inhibits SARS-CoV-2 infection. | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | E1342 | 
                                    
                                        
                                        
                                            Sebetralstat
                                        
                                     | 
                                    Sebetralstat(KVD900) is a plasma kallikrien inhibitor. | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | E6013New | 
                                    
                                        
                                        
                                            Sivelestat sodium
                                        
                                     | 
                                    Sivelestat sodium (ONO-5046, Sodium sivelestat, LY544349 sodium) is a potent, specific, and intravenously active inhibitor of neutrophil elastase with an IC50 value of 44 nm. It is a useful agent for studying the roles of neutrophil elastase in animal disease models such as emphysema, adult respiratory distress syndrome, septic shock and disseminated intravascular coagulation in COVID-19.  | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | E1014 | 
                                    
                                        
                                        
                                            Upamostat (WX-671)
                                        
                                     | 
                                    Upamostat (WX-671), a novel serine protease urokinase (uPA) inhibitor by inhibiting the urokinase-type plasminogen activator (uPA) system. | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                                
                                    | S0479 | 
                                    
                                        
                                        
                                            ZK824859
                                        
                                     | 
                                    ZK824859 is a potent, selective and orally bioavailable inhibitor of urokinase plasminogen activator (uPA) with IC50 of 79 nM, 1580 nM and 1330 nM for human uPA, tPA, and plasmin, respectively. | 
                                    
                                        
                                     | 
                                    
                                        
                                     | 
                                
                            
                        
                    
                    
                        
                        
                            
                                
                                    
                                        | S7380 | 
                                        
                                            
                                            Leupeptin Hemisulfate
                                                    
                                         | 
                                        Leupeptin Hemisulfate is a reversible inhibitor of serine and cysteine proteases. It inhibits cathepsin B (Ki = 6 nM), calpain (Ki = 10 nM), trypsin (Ki = 35 nM), plasmin (Ki = 3.4 μM), and kallikrein (Ki = 19 μM), and has no effect against chymotrypsin, elastase, renin, or pepsin. | 
                                        
                                            
                                                
                                                    
                                                        - Adv Mater, 2025, e18445.
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Nat Commun, 2025, 16(1):4069
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - J Adv Res, 2025, S2090-1232(25)00056-6
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S3025 | 
                                        
                                            
                                            PMSF 
                                                    
                                         | 
                                        PMSF (Phenylmethylsulfonyl Fluoride, Benzylsulfonyl fluoride) is an irreversible serine/cysteine protease inhibitor. | 
                                        
                                            
                                                
                                                    
                                                        - Cell Death Discov, 2024, 10(1):171
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Cell Biosci, 2023, 13(1):9
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Cell Biosci, 2023, 13(1):9
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S1811 | 
                                        
                                            
                                            Amiloride HCl
                                                    
                                         | 
                                        Amiloride HCl is a selective T-type calcium channel blocker, an epithelial sodium channel blocker and a selective inhibitor of urokinase plasminogen activator (uPA)(Ki=7 μM). | 
                                        
                                            
                                                
                                                    
                                                        - J Extracell Vesicles, 2024, 13(4):e12426
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - J Extracell Vesicles, 2024, 13(4):e12426
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Virus Res, 2024, 339:199258
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S1386 | 
                                        
                                            
                                            Nafamostat mesilate (FUT-175)
                                                    
                                         | 
                                        Nafamostat mesilate is a synthetic serine protease inhibitor, used as an anticoagulant during hemodialysis. Nafamostat mesylate blocks activation of SARS-CoV-2 and is investigated as a new treatment option for COVID-19. Nafamostat Mesilate attenuates inflammation and apoptosis. | 
                                        
                                            
                                                
                                                    
                                                        - J Immunother Cancer, 2024, 12(11)e009805
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Cell Death Dis, 2024, 15(2):109
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - CNS Neurosci Ther, 2024, 30(6):e14822
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                                
                                                     
                                                
                                            
                                         | 
                                    
                                
                                    
                                        | S8136 | 
                                        
                                            
                                            Sivelestat
                                                    
                                         | 
                                        Sivelestat is a potent and selective inhibitor of neutrophil elastase with IC50 of 44nM. It almost shows no activity at a range of other proteases. | 
                                        
                                            
                                                
                                                    
                                                        - Redox Biol, 2025, 87:103881
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - J Immunother Cancer, 2025, 13(2)e010813
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Int Immunopharmacol, 2025, 151:114340
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S7378 | 
                                        
                                            
                                            AEBSF HCl
                                                    
                                         | 
                                        AEBSF HCl is a broad spectrum, irreversible serine protease inhibitor.
 | 
                                        
                                            
                                                
                                                    
                                                        - Acta Pharm Sin B, 2024, 14(6):2554-2566
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Int J Med Sci, 2024, 21(7):1204-1212
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Int J Biol Sci, 2023, 19(13):4327-4339
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S4666 | 
                                        
                                            
                                            Sivelestat sodium tetrahydrate
                                                    
                                         | 
                                        Sivelestat sodium tetrahydrate (ONO5046-Na, EI546, LY544349) is a competitive inhibitor of human neutrophil elastase, also inhibits leukocyte elastase obtained from rabbit, rat, hamster and mouse. | 
                                        
                                            
                                                
                                                    
                                                        - J Thorac Dis, 2024, 16(10):6616-6633
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - J Immunol, 2021, 206(4):797-806
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Aging (Albany NY), 2020, 12(17):16820-16836
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S2101 | 
                                        
                                            
                                            Gabexate Mesylate
                                                    
                                         | 
                                        Gabexate Mesylate(FOY) is a serine protease inhibitor with IC50 of 0.19 μM which is used therapeutically in the treatment of pancreatitis and disseminated intravascular coagulation. | 
                                        
                                            
                                                
                                                    
                                                        - iScience, 2024, 27(10):110862
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Curr Res Chem Biol, 2022, 2:100023
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Front Oncol, 2019, 0.87569444444
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                                
                                                     
                                                
                                            
                                         | 
                                    
                                
                                    
                                        | S7218 | 
                                        
                                            
                                            Alvelestat (AZD9668)
                                                    
                                         | 
                                        Alvelestat (AZD9668, Avelestat) is an oral, highly selective inhibitor of neutrophil elastase (NE) with IC50 and Ki of 12 nM and 9.4 nM, at least 600-fold more selective over other serine proteases.
 Phase 2.
 | 
                                        
                                            
                                                
                                                    
                                                        - Cell Death Discov, 2025, 11(1):29
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Int Immunopharmacol, 2025, 159:114860
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Proc Natl Acad Sci U S A, 2021, 118(34)e2102435118
 
                                                     
                                                
                                            
                                                
                                            
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S8457 | 
                                        
                                            
                                            UK-371804 HCl
                                                    
                                         | 
                                        UK-371804 is a potent and selective urokinase-type plasmogen activator (uPA) inhibitor with excellent enzyme potency (Ki=10 nM) and selectivity profile (4000-fold versus tPA and 2700-fold versus plasmin). | 
                                        
                                            
                                                
                                                    
                                                        - PNAS Nexus, 2022, 1(3):pgac104
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Front Genet, 2021, 12:651882
 
                                                     
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S7377 | 
                                        
                                            
                                            Aprotinin
                                                    
                                         | 
                                        Aprotinin is a small protein serine protease inhibitor (Kd=0.06 pM for bovine β-trypsin), used to reduce perioperative blood loss and transfusion.
 | 
                                        
                                            
                                                
                                                    
                                                        - Front Cell Neurosci, 2025, 19:1623747
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - J Immunother Cancer, 2024, 12(11)e009805
 
                                                     
                                                
                                            
                                                
                                                    
                                                        - Elife, 2021, 10e65962
 
                                                     
                                                
                                            
                                                
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | E7249New | 
                                        
                                            
                                            Ulinastatin
                                                    
                                         | 
                                        Ulinastatin (Uristatin) is the main inhibitor of a hydrolase protein and serine protease suppresses trypsin, chymotrypsin, and other pancreatic proteases. It can inhibit the production and release of inflammatory factors through mediating inflammatory pathways, while modulating apoptosis, enzyme activity, coagulation, and immune responses. It is effective in preventing and managing conditions like pancreatitis, cerebral edema, acute respiratory distress, circulatory failure, sepsis, and systemic inflammatory response syndrome. | 
                                        
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S0042 | 
                                        
                                            
                                            Fulacimstat
                                                    
                                         | 
                                        Fulacimstat (BAY1142524) is an orally available inhibitor of chymase with IC50 of 4 nM and 3 nM for human and hamster chymase enzyme, respectively. | 
                                        
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S3511 | 
                                        
                                            
                                            FOY251
                                                    
                                         | 
                                        FOY251, an active metabolite of camostat mesilate, is an inhibitor of synthetic serine protease. FOY251 inhibits SARS-CoV-2 infection. | 
                                        
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | E1342 | 
                                        
                                            
                                            Sebetralstat
                                                    
                                         | 
                                        Sebetralstat(KVD900) is a plasma kallikrien inhibitor. | 
                                        
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | E6013New | 
                                        
                                            
                                            Sivelestat sodium
                                                    
                                         | 
                                        Sivelestat sodium (ONO-5046, Sodium sivelestat, LY544349 sodium) is a potent, specific, and intravenously active inhibitor of neutrophil elastase with an IC50 value of 44 nm. It is a useful agent for studying the roles of neutrophil elastase in animal disease models such as emphysema, adult respiratory distress syndrome, septic shock and disseminated intravascular coagulation in COVID-19.  | 
                                        
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | E1014 | 
                                        
                                            
                                            Upamostat (WX-671)
                                                    
                                         | 
                                        Upamostat (WX-671), a novel serine protease urokinase (uPA) inhibitor by inhibiting the urokinase-type plasminogen activator (uPA) system. | 
                                        
                                            
                                         | 
                                        
                                            
                                         | 
                                    
                                
                                    
                                        | S0479 | 
                                        
                                            
                                            ZK824859
                                                    
                                         | 
                                        ZK824859 is a potent, selective and orally bioavailable inhibitor of urokinase plasminogen activator (uPA) with IC50 of 79 nM, 1580 nM and 1330 nM for human uPA, tPA, and plasmin, respectively. | 
                                        
                                            
                                         | 
                                        
                                            
                                         |